tiprankstipranks
iTeos Therapeutics expects cash to provide runway into 2026
The Fly

iTeos Therapeutics expects cash to provide runway into 2026

The Company’s cash, cash equivalents and investments position was $731.4 million as of December 31, 2022, as compared to $848.5 million of cash and cash equivalents as of December 31, 2021. The Company continues to expect its cash and investment position to provide runway into 2026.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ITOS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles